KaliVir Immunotherapeutics
kalivir.com
Biotechnology
KaliVir Immunotherapeutics develops oncolytic virus therapies that target and destroy cancer cells, enhancing the immune response against tumors. Their innovative approach aims to provide effective treatments for various types of cancer.
Founded
2019
Total Funding
$10M+
Total Rounds
1
First Raise
Aug 19, 2026
Latest Raise
Aug 19, 2026
Get notified when KaliVir Immunotherapeutics and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/19/2026 | |||
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
KaliVir Immunotherapeutics 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free